Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study
Lionel Piroth(Centre Hospitalier Universitaire Dijon Bourgogne), Anne Minello(Inserm), Vincent Di Martino(Centre Hospitalier Universitaire de Besançon), Tahar Hadou(Centre Hospitalier Régional et Universitaire de Nancy), Yves Hansmann(Hôpitaux Universitaires de Strasbourg), Alain Lozniewski(Centre Hospitalier Régional et Universitaire de Nancy), Christian Rabaud, B. Jaulhac(Institut Pasteur), Isabelle Patry(Centre Hospitalier Universitaire de Besançon), Catherine Chirouze(Centre Hospitalier Universitaire de Besançon), A. Péchinot(Centre Hospitalier Universitaire Dijon Bourgogne), P. Chavanet(Université de Bourgogne), Catherine Neuwirth(Université de Bourgogne), Alain Putot(Centre Hospitalier Universitaire Dijon Bourgogne)
Cited by 73
Related Papers
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
|EBioMedicine|2021|239
Coagulase-Negative Staphylococci Pathogenomics
|International Journal of Molecular Sciences|2019|219
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
|American Journal of Obstetrics and Gynecology|2020|197